FDA broadens label for Amgen’s Uplizna as it enters rare disease competitionnews2025-12-12T12:03:56+00:00December 12th, 2025|Endpoints News|
CDC report underscores benefit of Covid-19 vaccines in kidsnews2025-12-11T20:51:34+00:00December 11th, 2025|Endpoints News|
GSK’s new antibiotic wins gonorrhea approvalnews2025-12-11T19:19:37+00:00December 11th, 2025|Endpoints News|
USAntibiotics scores sped-up approval for amoxicillinnews2025-12-10T19:11:01+00:00December 10th, 2025|Endpoints News|
In a first, FDA approves a gene therapy from a nonprofitnews2025-12-10T16:02:33+00:00December 10th, 2025|Endpoints News|
FDA is taking another look at safety of approved RSV antibodiesnews2025-12-09T21:02:59+00:00December 9th, 2025|Endpoints News|
FDA’s probe of Covid-19 vaccines expands into adultsnews2025-12-09T19:22:12+00:00December 9th, 2025|Endpoints News|
FDA sets new, higher bar for CAR-T cancer treatments to prove superioritynews2025-12-08T19:57:56+00:00December 8th, 2025|Endpoints News|
FDA misses PDUFA review deadline for Agios’ thalassemia drugnews2025-12-08T18:08:34+00:00December 8th, 2025|Endpoints News|
Bristol Myers expands Breyanzi approval to marginal zone lymphomanews2025-12-05T19:17:02+00:00December 5th, 2025|Endpoints News|
